Dr Latha Subramanian, MD in Anchorage, AK - Medicare Specialist

Dr Latha Subramanian, MD is a medicare enrolled "Specialist" physician in Anchorage, Alaska. Her current practice location is 4048 Laurel St, Ste 305, Anchorage, Alaska. You can reach out to her office (for appointments etc.) via phone at (907) 569-2627.

Dr Latha Subramanian is licensed to practice in Alaska (license number AA2285) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1841262201.

Contact Information

	Dr Latha Subramanian, MD
	4048 Laurel St, Ste 305, Anchorage, AK 99508-5391
	(907) 569-2627
	(907) 569-2626

Physician's Profile

Full Name	Dr Latha Subramanian
Gender	Female
Speciality	Specialist
Location	4048 Laurel St, Anchorage, Alaska
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1841262201
Provider Enumeration Date: 02/01/2006
Last Update Date: 03/07/2023

Medicare PECOS Information:

PECOS PAC ID: 8820012735
Enrollment ID: I20060118000864

Medical Identifiers

Medical identifiers for Dr Latha Subramanian such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1841262201	NPI	-	NPPES
AA2285	Other	AK	STATE LICENSE
MD2285	Medicaid	AK

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RH0000X	Internal Medicine - Hematology	AA2285 (Alaska)	Secondary
207RH0003X	Internal Medicine - Hematology & Oncology	AA2285 (Alaska)	Secondary
207RX0202X	Internal Medicine - Medical Oncology	AA2285 (Alaska)	Secondary
174400000X	Specialist	AA2285 (Alaska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Latha Subramanian is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Latha Subramanian, MD 4048 Laurel St, Ste 305, Anchorage, AK 99508-5391 Ph: (907) 569-2627	Dr Latha Subramanian, MD 4048 Laurel St, Ste 305, Anchorage, AK 99508-5391 Ph: (907) 569-2627

News Archive

New report highlights the need for disclosing Alzheimer's diagnosis to patients

The Alzheimer's Association's 2015 Alzheimer's Disease Facts and Figures report, released today, found that only 45 percent of people with Alzheimer's disease or their caregivers say they were told the diagnosis by their doctor.

Emory Institute of Drug Discovery and Zirus collaborate to develop new anti-viral drugs

The Emory Institute of Drug Discovery and Zirus, Inc., a biotechnology company based in Buford, Georgia, have entered into a collaboration and research agreement to develop novel compounds to treat infectious disease. Zirus uses a proprietary method for identifying genes and gene products in host cells that, when blocked, can prevent viruses from multiplying. Over the past several years, either alone or in collaboration with partners, including the Centers for Disease Control and Prevention (CDC), Zirus has identified, licensed and filed patents on more than 1000 targets.

Experimental drug therapy could open new window for treatment of deadly stroke

A new type of drug therapy that is currently being tested in Canada could significantly reduce the death rate caused by the deadliest form of stroke. According to the Canadian Heart and Stroke Foundation, new developments in stroke research make it more important than ever that Canadians recognize and react to the warning signs of stroke.

Study estimates total annual costs for five major health care-associated infections

A study estimates that total annual costs for five major health care-associated infections (HAIs) were $9.8 billion, with surgical site infections contributing the most to overall costs, according to a report published by JAMA Internal Medicine, a JAMA Network publication.

Mild prenatal stressors increase risk of developing neuropsychiatric illness during adulthood

Learning and memory impairments are important contributors to the disability associated with schizophrenia. These functional impairments emerge long before the onset of other symptoms associated with schizophrenia, suggesting that they are a consequence of a disturbance in brain development.

Dr Latha Subramanian, MD - Medicare Specialist in Anchorage, AK